Possibia

1971515

Last Update Posted: 2018-09-19

Recruiting has ended

All Genders

accepted

18 Years +

101 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies

This is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity signals of MSC2363318A.

Eligibility

Relevant conditions:

Solid Tumor

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov